SMAD4 and cancer: SMAD4 has been reported to be frequently mutated in multiple oral cancer cell lines such as CAL-27, CAL-33, and UM-SCC-2, and is a driving factor for altering the antiproliferative function of TGF-β signaling in many cancers [60].